283
vival benefit when compared to ‘watch and wait’ (WW) [
R
= 0.50,
P
= 0.18, 95% CI = 0.19–1.36,
I
2
= 48%]. There was strong evi-
dence favouring END at an earlier disease stage with the weighted
odds of regional recurrence 9 times lower than the WW group
[OR = 0.09,
P
< 0.0001, 95% CI = 0.05–0.16,
I
2
= 0%].
Conclusions:
END is the gold standard treatment for small tongue
SCC without clinically detectable nodes. Although there appeared
to be no superior survival benefit subjecting patients to END, sub-
sequent management can be guided by the histological finding
from the neck specimen.
Observation remains a conservative alternative to early neck
intervention provided a stringent follow up scheme is strictly
adhered to. Immediate surgical intervention when lymph node
remains small is the key to high salvage rate and overall survival
outcome.
http://dx.doi.org/10.1016/j.ijom.2017.02.951Nasogastric feeding tube placement in head and neck
oncology patients
R.J. Clark
∗
, T.D. Dickens
The University of Bristol, Bristol, United Kingdom
Background:
Nasogastric (NG) feeding is important for a suc-
cessful recovery in many postoperative head and neck cancer
patients. There have been 21 deaths in England since 2005 as
a result of misplaced feeding tubes. Misplaced NG feeding tubes
are a ‘never event’ in the Leeds Teaching Hospital Trust.
Method:
Retrospective analysis of the notes of 80 head and neck
oncology patients who underwent surgery between 2014 and 2015
and required NG feeding tube (NGFT) postoperative placement.
Completed over four three-monthly cycles.
Results:
For the first six months, 50% of patients had no record
of NGFT postoperative placement and in 70% of cases the length
of insertion was not recorded. After the introduction of a new
oncology clerking proforma and further staff training, placement
was correctly recorded in 100% of patients.
Conclusion:
Repeat audit cycles and analysis of the data localised
the failures in documentation completion to placement of the
NGFT in theatres. With a new oncology clerking proforma and
further training to the entire oral and maxillofacial surgery team, I
successfully improved the completion rate of the NGFT placement
documentation.
http://dx.doi.org/10.1016/j.ijom.2017.02.952The immunological impact of chemotherapy on the tumour
microenvironment of oral squamous cell carcinoma
S. Domae
∗
, H. Takakura, Y. Kunisada, T. Ono, A. Sasaki,
I. Asahina
Nagasaki University Graduate School of Biomedical Sciences,
Japan
Background:
The immune system plays an important role in
the development and progression of cancers, including oral squa-
mous cell carcinoma (OSCC). However, little is known about the
immune response in the tumour microenvironment after neoadju-
vant chemotherapy.
Objective:
To investigate the immunological impact of
chemotherapy in the tumour microenvironment of OSCC.
Methods:
We retrospectively analysed a degree of immune cell
infiltration and relevance of the programmed death ligand-1 (PD-
L1) expression in surgically resected eighteen OSCC specimens
from patients with or without pretreatment of certain chemother-
apy.
Results:
No distinct difference was observed on the degree of
immune-cell infiltration between two groups. A decreased num-
ber of programmed death-1 (PD-1) positive cells were found in
the specimens of cancer nest of the neoadjuvant chemotherapy
group. In the without neoadjuvant chemotherapy group, 80%spec-
imens showed intermediate to strong expression of PD-L1 protein.
Whereas most of the specimens of the neoadjuvant chemotherapy
group (75%) showed weak expression.
Conclusion:
Neoadjuvant chemotherapy in OSCC is useful to
induce the number of tumour-infiltrating lymphocytes in the
tumour microenvironment. And it was revealed that the expression
of PD-L1 changed by the chemotherapeutic agents.
http://dx.doi.org/10.1016/j.ijom.2017.02.953The rate of phrenic nerve injury following neck dissection for
head and neck cancer and its impact on length of hospital
stay
O. Dugena
∗
, S. Islam, J. Hayter
Department of Maxillofacial/Head and Neck Surgery University
Hospitals Leicester, Leicester, United Kingdom
Background:
The published rate of phrenic nerve injury follow-
ing head and neck cancer surgery is highly variable and there is
a paucity of data regarding its impact on postoperative recovery.
Our aim was to investigate the prevalence of phrenic nerve dam-
age following neck dissection for oral cavity malignancy and to
explore its association with postoperative length of hospital stay.
Method:
We reviewed the clinical records of 100 consecutive
patients who underwent a neck dissection for oral cancer. We
assessed both the pre and postoperative chest radiographs for
evidence of phrenic nerve injury. Data pertaining to stage of dis-
ease, type of neck dissection, pre-existing respiratory disorders,
patients’ performance status and postoperative length of hospital
stay were collected from the medical treatment records.
Findings:
93 patients met our inclusion criteria. 9% had a radio-
logical evidence of postoperative unilateral phrenic nerve injury.
Only 1 patient underwent a radical neck dissection and in most
patients (
n
= 7) the nerve injury was noted incidentally on chest
radiographs after a selective neck dissection. The median length of
stay was compared and patients with phrenic nerve injury stayed
for median of 16 days versus a median of 15 days for the overall
cohort (Mann–Whitney
U
,
P
= 0.86).
Conclusion:
Unilateral phrenic nerve injury is a common inciden-
tal finding following neck dissection. Most of these are usually
transient or found to have no clinical significance. Our study
demonstrates a rate of unilateral phrenic nerve injury to be 9%
with no statistically significant association with increased length
of hospital stay.
http://dx.doi.org/10.1016/j.ijom.2017.02.954




